Radiotherapy Plus Procarbazine, Lomustine, and Vincristine Versus Radiotherapy Plus Temozolomide for IDH‐Mutant Anaplastic Astrocytoma: A Retrospective Multicenter Analysis of the French POLA Cohort

BACKGROUND: IDH‐mutant anaplastic astrocytomas (AAs) are chemosensitive tumors for which the best choice of adjuvant chemotherapy between procarbazine, lomustine, and vincristine (PCV) or temozolomide (TMZ) after radiotherapy (RT) remains unclear. METHODS: In a large cohort of patients with histolog...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncologist
Auteurs principaux: Esteyrie, Vincent, Dehais, Caroline, Martin, Elodie, Carpentier, Catherine, Uro‐Coste, Emmanuelle, Figarella‐Branger, Dominique, Bronniman, Charlotte, Pouessel, Damien, Ciron, Delphine Larrieu, Ducray, François, Moyal, Elizabeth Cohen‐Jonathan, Network, Pola
Format: Artigo
Langue:Inglês
Publié: John Wiley & Sons, Inc. 2021
Sujets:
Neuro‐Oncology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8100568/
https://ncbi.nlm.nih.gov/pubmed/33524191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13701
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires